In contrast, TRAs involved in RXRA, KDM5B, STAT1, GATA1, HDAC1, RCOR1, PHF8, and CHD2 appeared to be selectively mutated in transformed AML cells during Aza treatment. This evidence concerns the gene RCOR1 and acute myeloid leukemia.